A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

Published:2015-10-06 Issue:4 Volume:117 Page:576-583
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Randazzo Marco¹²,Müller Alexander¹,Carlsson Sigrid³⁴,Eberli Daniel¹,Huber Andreas⁵,Grobholz Rainer⁶,Manka Lukas⁷,Mortezavi Ashkan¹,Sulser Tullio¹,Recker Franz²,Kwiatkowski Maciej²⁷

Affiliation:

1. Department of Urology; University Hospital Zürich; Zürich Switzerland

2. Department of Urology; Cantonal Hospital Aarau; Aarau Switzerland

3. Department of Surgery (Urology Service); Memorial Sloan Kettering Cancer Center; New York NY USA

4. Department of Urology; Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

5. Department of Laboratory Medicine; Cantonal Hospital Aarau; Aarau Switzerland

6. Department of Pathology; Cantonal Hospital Aarau; Aarau Switzerland

7. Department of Urology; Academic Hospital Braunschweig; Braunschweig Germany

Funder

The Horten Foundation

Aargau Cancer League

Swiss Cancer League

Health Department of Canton Aargau

Prostate Cancer Research Foundation

Baugarten Stiftung

Miss Messerli Foundation, Switzerland

AFA Insurance

National Cancer Institute made to Memorial Sloan Kettering Cancer Center

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13310/fullpdf

Reference36 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schröder;Lancet,2014

4. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

5. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-Specific Antigen-Era;Jahn;Int J Cancer,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer;World Journal of Urology;2024-08-08

2. A retrospective study of prostate-specific antigen and international prostate symptoms scores from participants at a men’s health screening initiative in Trinidad;Journal of Family Medicine and Primary Care;2024-07-26

3. Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review;BJUI Compass;2024-02-09

4. Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology;JCO Precision Oncology;2024-02

5. The Risk Factors and Screening Uptake for Prostate Cancer: A Scoping Review;Healthcare;2023-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3